Observational Terapevticheskii arkhiv · 2026 [Efficacy and safety of H. pylori eradication therapy in real-world clinical practice: results of the «PAMIR» observational program]. Alexeev NY, Astaf'eva TO, Vishnevskaya VV, et al. Bifidobacterium animalis PubMed ↗
Randomized trial Frontiers in cellular and infection microbiology · 2026 Probiotics alleviate oral microbiota disruptions induced by Helicobacter pylori eradication with vonoprazan-amoxicillin dual therapy: a randomized double-blind placebo-controlled trial. (An exploratory study). Wei W, Chen W, Peng R, et al. Enterococcus faecium PubMed ↗
Review Terapevticheskii arkhiv · 2026 [Probiotics' position in clinical practice: focus on the combination of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12). A review]. Gorelov AV, Kozlov RS, Andreeva IV, et al. Bifidobacterium animalis PubMed ↗
Randomized trial Scientific reports · 2025 Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study. Tokunaga E, Inoue J, Asaji N, et al. Enterococcus faecium PubMed ↗
Review Microbial pathogenesis · 2025 Plant and probiotic-based edible vaccines for Helicobacter pylori: Research status and application prospects. Ye S, Zhao J, Zhao S Lactococcus lactis PubMed ↗
Meta-analysis Frontiers in cellular and infection microbiology · 2025 Meta-analysis of H. pylori and the gut microbiome interactions and clinical outcomes. Wu X, Zhu H, Hu Y, et al. Bacteroides fragilisFaecalibacterium prausnitzii PubMed ↗
Randomized trial Nutrition journal · 2025 Impact of supplementing Limosilactobacillus fermentum MN-LF23 on the eradication of Helicobacter pylori with 14-day standard quadruple therapy: a randomized, double-blind, placebo-controlled trial. Zhao Y, Niu X, Zhang Y, et al. Bifidobacterium longum PubMed ↗
Randomized trial Journal of biomedical science · 2025 Probiotics ameliorate H. pylori-associated gastric β-catenin and COX-2 carcinogenesis signaling by regulating miR-185. Yang YJ, Wu CT, Cheng HC, et al. Bifidobacterium animalis PubMed ↗
Review Current microbiology · 2024 Is Lactococcus lactis a Suitable Candidate for Use as a Vaccine Delivery System Against Helicobacter pylori? Haghighi FH, Farsiani H Lactococcus lactis PubMed ↗
Systematic review Clinical nutrition ESPEN · 2024 Efficacy of probiotics regimens for Helicobacter pylori eradication: A systematic review, pairwise, and network meta-analysis of randomized controlled trials. Tanashat M, Abuelazm M, Abouzid M, et al. Bifidobacterium longum PubMed ↗
Randomized trial Helicobacter · 2024 Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication. Chen J, Zhang Y, Min H, et al. Enterococcus faecalisEnterococcus faeciumKlebsiella pneumoniae PubMed ↗
Review Beneficial microbes · 2023 Bifidobacterium adolescentis - a beneficial microbe. Leser T, Baker A Bifidobacterium adolescentis PubMed ↗
Review European journal of pediatrics · 2022 Are pro- and/or synbiotics beneficial in Helicobacter pylori eradication therapy in children? A narrative review. Daelemans S, Deseck V, Levy EI, et al. Bifidobacterium longum PubMed ↗
Randomized trial Nutrients · 2022 A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates. Viazis N, Argyriou K, Kotzampassi K, et al. Bifidobacterium animalis PubMed ↗
Observational Helicobacter · 2021 Helicobacter pylori and the intestinal microbiome among healthy school-age children. Lapidot Y, Reshef L, Cohen D, et al. Segatella copri PubMed ↗
Randomized trial Terapevticheskii arkhiv · 2021 [A prospective randomized comparative study of the efficacy and safety of a two-week bismuth-based quadrotherapy of Helicobacter pylori infection with the inclusion of the probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 ]. Yakovenko EP, Strokova TV, Iakovenko AV, et al. Bifidobacterium longumEnterococcus faecium PubMed ↗
The ISME journal · 2026 Bile acid metabolism dysregulation following Helicobacter pylori eradication promotes plasmid-mediated antimicrobial resistance in the gut microbiome. Zhang P, Zhao M, Cheng Z, et al. Escherichia coli PubMed ↗
BMC medicine · 2026 Impact of Helicobacter pylori infection on gut and intratumoral microbiome and its association with immunotherapy response in gastrointestinal cancer. Jia K, Chen Y, Dai D, et al. [Clostridium] leptumRuminococcus bromii PubMed ↗
Journal of agricultural and food chemistry · 2025 Inhibitory Effect of Fucoidan Combined with Bifidobacteria on Helicobacter pylori. Guo L, Xuan J, Bao S, et al. Bifidobacterium animalis PubMed ↗
International journal of medical microbiology · 2025 Lactobacillus gasseri suppresses the Helicobacter pylori-induced expression of the proliferation-associated factors HBEGF and TGF-α in gastric host cells. Somiah T, Paul P, Pilheden S, et al. Lactobacillus gasseri PubMed ↗
Scientific reports · 2025 Exploring compositional and predicted functional alterations of gut microbiota in H. pylori infection. Soliman NS, Soliman MS, Aziz HSA, et al. Phocaeicola vulgatus PubMed ↗
Journal of translational medicine · 2025 Fecal microbiota transplantation from Helicobacter pylori carriers following bismuth quadruple therapy exacerbates alcohol-related liver disease in mice via LPS-induced activation of hepatic TLR4/NF-κB/NLRP3 signaling. Gao H, Bai H, Su Y, et al. Escherichia coliKlebsiella pneumoniae PubMed ↗
BMC microbiology · 2025 Eradication of Helicobacter pylori reshapes gut microbiota and facilitates the evolution of antimicrobial resistance through gene transfer and genomic mutations in the gut. Zhao M, Zhang Y, Liu S, et al. Escherichia coli PubMed ↗
Letters in applied microbiology · 2024 Alleviation of Helicobacter pylori- or aspirin-induced gastritis and neuroinflammation in mice by Lactococcus lactis and Bifidobacterium longum. Shin JW, Shin YJ, Lee DY, et al. Bifidobacterium longumLactococcus lactis PubMed ↗
mSystems · 2024 Distinct oral-associated gastric microbiota and Helicobacter pylori communities for spatial microbial heterogeneity in gastric cancer. Lei L, Zhao L-Y, Cheng R, et al. Veillonella parvula PubMed ↗
Microbial pathogenesis · 2024 The modulatory effect of Lactobacillus gasseri ATCC 33323 on autophagy induced by extracellular vesicles of Helicobacter pylori in gastric epithelial cells in vitro. Sadeghloo Z, Saffarian P, Hakemi-Vala M, et al. Lactobacillus gasseri PubMed ↗
Letters in applied microbiology · 2024 A Bifidobacterium animalis subsp. lactis strain that can suppress Helicobacter pylori: isolation, in vitro and in vivo validation. Zheng Y, Zhang S, Zhang T, et al. Bifidobacterium animalis PubMed ↗
Helicobacter · 2024 Effect of Lactobacillus gasseri BIO6369 and Lacticaseibacillus rhamnosus BIO5326 on Gastric Carcinogenesis Induced by Helicobacter pylori Infection. Jauvain M, Lepied G, Bénéjat L, et al. Lactobacillus gasseri PubMed ↗
Journal of biosciences · 2024 Helicobacter pylori infection and gut microbiota in adolescents: Is there a relation? Amrousy DE, Ashry HE, Maher S, et al. Bacteroides fragilisEscherichia coli PubMed ↗
Microbiology spectrum · 2023 Gastric coinfection with thiopeptide-positive Cutibacterium acnes decreases FOXM1 and pro-inflammatory biomarker expression in a murine model of Helicobacter pylori-induced gastric cancer. Lunger C, Shen Z, Holcombe H, et al. Streptococcus salivarius PubMed ↗
BMC microbiology · 2022 Anti-Helicobacter pylori activity of potential probiotic Lactiplantibacillus pentosus SLC13. Thuy TTD, Kuo PY, Lin SM, et al. Lactobacillus gasseri PubMed ↗
Molecules · 2022 Microbial Proteins in Stomach Biopsies Associated with Gastritis, Ulcer, and Gastric Cancer. Aziz S, Rasheed F, Akhter TS, et al. Bacteroides fragilis PubMed ↗
Oncoimmunology · 2022 Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors. Tonneau M, Nolin-Lapalme A, Kazandjian S, et al. Alistipes finegoldiiBacteroides xylanisolvensDorea formicigeneransEubacterium ventriosum +1 more PubMed ↗
Frontiers in cellular and infection microbiology · 2022 The Potential Role of Hypochlorhydria in the Development of Duodenal Dysbiosis: A Preliminary Report. Filardo S, Scalese G, Virili C, et al. Streptococcus salivarius PubMed ↗
mSphere · 2022 Gastric Non-Helicobacter pylori Urease-Positive Staphylococcus epidermidis and Streptococcus salivarius Isolated from Humans Have Contrasting Effects on H. pylori-Associated Gastric Pathology and Host Immune Responses in a Murine Model of Gastric Cancer. Shen Z, Dzink-Fox J, Feng Y, et al. Streptococcus salivarius PubMed ↗
Animal study Probiotics and antimicrobial proteins · 2024 Oral Live-Carrier Vaccine of Recombinant Lactococcus lactis Inducing Prophylactic Protective Immunity Against Helicobacter pylori Infection. Ni X, Liu Y, Sun M, et al. Lactococcus lactis PubMed ↗
Animal study Gut microbes · 2023 Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection. Luo S, Ru J, Mirzaei MK, et al. Enterococcus faecalis PubMed ↗
Animal study Food & function · 2022 Two novel lactic acid bacteria, Limosilactobacillus fermentum MN-LF23 and Lactobacillus gasseri MN-LG80, inhibited Helicobacter pylori infection in C57BL/6 mice. Zhao Y, Li Z, Zhao L, et al. Lactobacillus gasseri PubMed ↗
Animal study Helicobacter · 2022 Probiotics mitigate Helicobacter pylori-induced gastric inflammation and premalignant lesions in INS-GAS mice with the modulation of gastrointestinal microbiota. He C, Peng C, Xu X, et al. Ligilactobacillus salivarius PubMed ↗
Observational Disease markers · 2020 Fecal Microbiome Alteration May Be a Potential Marker for Gastric Cancer. Wu J, Zhang C, Xu S, et al. Ligilactobacillus salivariusStreptococcus salivarius PubMed ↗